Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 5/20 | 0.61 |
| ▸ | LMNA | P02545 | 2/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.52 |
| ▸ | ACHE | P22303 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.52 |
| ▸ | HSP90AA1 | P07900 | 3/20 | 0.51 |
| ▸ | HTT | P42858 | 3/20 | 0.51 |
| ▸ | MAPT | P10636 | 2/20 | 0.51 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.51 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.51 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | CES2 | O00748 | 1/20 | 0.48 |
| ▸ | CES1 | P23141 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | MITF | O75030 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methyl Alcohol SCHEMBL28555835 | 0.94 | TSHR (0.55) | TSHRLMNAALDH1A1ACHETDP1 | |
| SCHEMBL11237941 | 0.90 | TSHR (0.50) | TSHRLMNAALDH1A1ACHETDP1 | |
| SCHEMBL11443206 | 0.89 | TSHR (0.53) | TSHRLMNAALDH1A1ACHETDP1 | |
| SCHEMBL11223757 | 0.87 | TSHR (0.47) | TSHRLMNAALDH1A1ACHETDP1 | |
| SCHEMBL11226239 | 0.86 | LMNA (0.46) | TSHRLMNAALDH1A1ACHETDP1 | |
| SCHEMBL11451626 | 0.85 | LTA4H (0.49) | TSHRLMNAALDH1A1ACHETDP1 | |
| SCHEMBL28728423 | 0.83 | TSHR (0.67) | TSHRLMNAALDH1A1ACHETDP1 | |
| SCHEMBL96231 | 0.82 | TSHR (0.64) | TSHRLMNAALDH1A1ACHETDP1 | |
| Nitrobenzene SCHEMBL28863803 | 0.80 | ALDH1A1 (0.57) | TSHRLMNAALDH1A1TDP1ALOX15 | |
| SCHEMBL3743169 | 0.80 | TSHR (0.61) | TSHRLMNAALDH1A1ACHETDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 151 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119680640-A | Alkyne selective hydrogenation catalyst with high activity and high selectivity and preparation method thereof | 甬江实验室 | 2025-03-25 | — | — | CN | claimed |
| CN-115872993-B | Method for continuously synthesizing piperidone by photoinduction | 南京工业大学 | 2024-12-10 | — | — | CN | claimed |
| CN-117964495-A | Method for synthesizing 3-aminophenylacetylene | 中国石油化工股份有限公司 | 2024-05-03 | — | — | CN | claimed |
| CN-113117724-B | Recoverable supported Au52Cu72 (SR) 55 cluster catalyst and application thereof | 安徽大学 | 2023-09-08 | — | — | CN | claimed |
| CN-115872993-A | Method for continuously synthesizing piperidone through photoinduction | 南京工业大学 | 2023-03-31 | — | — | CN | claimed |
| CN-115650816-A | Method for synthesizing 1, 3-diacetylene compound through heterogeneous catalysis | 成都理工大学 | 2023-01-31 | — | — | CN | claimed |
| CN-115445626-A | Catalyst for preparing aminophenylacetylene by hydrogenation of nitrobenzene-acetylene | 长春工业大学 | 2022-12-09 | — | — | CN | claimed |
| CN-113248455-A | 3, 5-disubstituted isoxazole derivatives and synthesis method thereof | 湖北科技学院 | 2021-08-13 | — | — | CN | claimed |
| CN-113117724-A | Recoverable supported Au52Cu72(SR)55 cluster catalyst and application thereof | 安徽大学 | 2021-07-16 | — | — | CN | claimed |
| EP-3051946-B1 | USE OF SUBSTITUTED DIHYDROOXINDOLYLSULFONAMIDES OR THEIR SALTS FOR INCREASING STRESS TOLERANCE IN PLANTS | BAYER CROPSCIENCE AG (DE) | 2017-11-29 | — | — | EP | claimed |
| CN-1130337-C | Process for synthesizing meta-aminophenylacetylene | UNIV HUADONG SCIENCE & ENG (CN) | 2003-12-10 | — | — | CN | claimed |
| CN-1313274-A | Process for synthesizing meta-aminophenylacetylene | HUADONG SCIENCE & ENGINEERING (CN) | 2001-09-19 | — | — | CN | claimed |
| US-4219679-A | HIGH CONVERSION | GULF RESEARCH & DEVELOPMENT COMPANY (US) | 1980-08-26 | — | — | US | claimed |
| US-4215226-A | TO THE AMINO SUBSTITUTED COMPOUNDS | GULF RESEARCH & DEVELOPMENT COMPANY (US) | 1980-07-29 | — | — | US | claimed |
| CN-122011069-A | Antitumor 1,2, 3-triazole-alpha-L-threose nucleoside phosphonate analogue and preparation method and application thereof | 河南警察学院 | 2026-05-12 | — | — | CN | disclosed |
| US-12595258-B2 | Heterocyclic derivatives, pharmaceutical compositions and their use in the treatment or amelioration of cancer | TOLREMO THERAPEUTICS AG (CH) | 2026-04-07 | — | — | US | disclosed |
| CN-223959657-U | Synthesis device of m-nitrophenylacetylene | 内蒙古习尚喜新材料科技有限公司 | 2026-03-03 | — | — | CN | disclosed |
| US-4128588-A | PALLADIUM-PHOSPHINE COMPLEX CATALYST | GULF RESEARCH & DEVELOPMENT COMPANY (US) | 1978-12-05 | — | — | US | disclosed |
| US-4125563-A | Process for making nitroarylacetylenes and nitroarylaldehydes | HUGHES AIRCRAFT COMPANY (US) | 1978-11-14 | — | — | US | disclosed |
| US-3975537-A | SUBSTITUTED BENZOFURANS | SMITH KLINE (US) | 1976-08-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12595258-B2 | Heterocyclic derivatives, pharmaceutical compositions and their use in the treatment or amelioration of cancer | SLC10A1, MAPT, SLC6A6 | TSHR 3591/4885LMNA 1609/4885ALDH1A1 1234/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.